Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_3

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 3Large-scale testing

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (50.0%)

N/A1 (50.0%)

Trials by Status

completed267%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

Study of Light Treatment and Laser Treatment for Melasma

NCT00509977

unknown

Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment.

NCT02224586

completedphase_3

Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression

NCT00958204

Clinical Trials (3)

Showing 3 of 3 trials

NCT00509977Not Applicable

Study of Light Treatment and Laser Treatment for Melasma

Completed

NCT02224586

Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment.

Unknown

NCT00958204Phase 3

Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3